July 18, 2026 a 09:00 am

ZBH: Analysts Ratings - Zimmer Biomet Holdings, Inc.

Historical Stock Grades

Analyst recommendations for Zimmer Biomet Holdings, Inc. show a strong preference towards a "Hold" position. The fluctuation in "Strong Buy" ratings suggests changes in analyst confidence over the months.

Recommendation	Number	Visualization
Strong Buy	2
Buy	6
Hold	18
Sell	1
Strong Sell	0

Sentiment Development

The ratings for Zimmer Biomet show a shift over the months, with a movement away from "Strong Buy" towards "Hold". This suggests growing caution among analysts.

• The total number of "Strong Buy" recommendations has decreased from an initial high in mid-2025 to a current low, reflecting reduced confidence.
• Conversely, "Hold" ratings have seen a significant increase, highlighting a neutral to cautious outlook.
• The "Sell" and "Strong Sell" recommendations remained relatively stable, indicating limited bearish sentiments.

Percentage Trends

Analyzing the data reveals a marked transition from bullish to more neutral or cautious sentiments among analysts for ZBH over the past year.

• The drop in "Strong Buy" percentage from 30% to about 6% exemplifies the shift towards conservatism.
• "Hold" has grown from 36% to over 54% in the current assessments, underscoring the reserved stance.
• The accompanying stagnation in "Sell" and "Strong Sell" percentages suggests that while optimism has waned, pessimism has not increased.
• There’s an observable trend towards stability, with more analysts opting to recommend maintaining positions rather than initiating new purchases.

Latest Analyst Recommendations

Recent analyses continue to echo a stable but cautious sentiment with little change in enthusiasm for the stock.

Date	New Recommendation	Last Recommendation	Publisher
2026-07-09	Market Perform	Outperform	BMO Capital
2026-07-06	Outperform	Outperform	Evercore ISI Group
2026-05-28	Neutral	Neutral	Citigroup
2026-04-29	Buy	Buy	Stifel
2026-04-29	Market Outperform	Market Outperform	Citizens

Analyst Recommendations with Change of Opinion

There have been significant downgrades in recent months, reflecting uncertainty in the market perception for Zimmer Biomet.

Date	New Recommendation	Last Recommendation	Publisher
2026-07-09	Market Perform	Outperform	BMO Capital
2026-03-23	Neutral	Buy	BTIG
2026-01-05	Outperform	In Line	Evercore ISI Group
2025-12-16	Neutral	Outperform	Baird
2025-11-06	Neutral	Overweight	JP Morgan

Interpretation

The analysis of Zimmer Biomet’s stock reveals a market perception that is currently in flux. The decrease in "Strong Buy" and "Buy" recommendations indicates a shift towards neutrality and caution. Increasing "Hold" ratings suggest that analysts are adopting a wait-and-see approach. Overall, the data suggests a lack of strong confidence, coupled with a stable yet conservative market outlook.

Conclusion

Zimmer Biomet Holdings, Inc. is experiencing a period characterized by caution and neutrality among market analysts. While fundamental business operations remain strong, market sentiment reflects tepid confidence and increased skepticism regarding near-term performance. This shift underscores a potential reevaluation of growth prospects or sector pressures. Investors are advised to weigh the stability of the overall market for healthcare reconstruction products against these sentiments and consider the implications of external economic variables on the company's strategic direction.